CN Patent

CN101784266B — 氢溴酸安非他酮以及治疗的应用

Assigned to Valente International (barbados) Ltd · Expires 2012-07-18 · 14y expired

What this patent protects

在此说明了氢溴酸安非他酮的配制品连同它们用于治疗多种病症的用途。

USPTO Abstract

在此说明了氢溴酸安非他酮的配制品连同它们用于治疗多种病症的用途。

Drugs covered by this patent

bupropion-hydrobromide (BUPROPION HYDROBROMIDE)

Patent Metadata

Patent number: CN101784266B
Jurisdiction: CN
Classification: —
Expires: 2012-07-18
Drug substance claim: No
Drug product claim: No
Assignee: Valente International (barbados) Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.